Skip to main content
. 2015 Feb 24;10(2):e0117818. doi: 10.1371/journal.pone.0117818

Fig 3. Fold Changes of DE genes (BT474 plus trastuzumab vs. BT474).

Fig 3

The barchart displays the log2 fold changes of validated candidate genes, which significantly changed their expression in BT474 after trastuzumab treatment. The positive values indicate an upregulation upon drug treatment. Black bars denote values resulting from RNA-Seq analysis. Gray bars denote values resulting from RT-qPCR analysis.